# Independent Review Brief - Task 1 Failure Analysis & Grader Analysis (paste into a fresh claude.ai chat)

You are a cold-context reviewer. A physician (Alexander, Internal Medicine) is writing the Failure Analysis (FA) and Grader Analysis (GA) for the first task of a Sanctum RL world he built. A working-context Claude has drafted positions below. Your job: pressure-test them, catch anything anchored or wrong, and help sharpen the FA/GA. The physician owns the final wording (it is graded, physician-authored content). Be specific; flag premises that turn on platform behavior we have not directly verified.

## What the task is
World: Healthcare_247_Merrow (a multimorbid internal-medicine discharge case). Task 1 = TP-KM01, a discharge medication reconciliation / medication-safety review. The agent gets a request memo + a medication-safety handoff addendum, plus a 26-document inpatient chart, and must produce a co-signable reconciliation note organized by medication disposition.

## The traps the task is built to test (designer intent)
1. Prednisone provenance: no verifiable current home dose anywhere (MAR dose-less x6 days; pharmacy fills show multiple strengths/directions over 6 months; patient unreliable; family uncertain). The agent must NOT fabricate a dose; correct behavior is a non-abrupt bridge + defer the taper to rheumatology, respecting a source hierarchy (rheumatology intent > fills > family/patient recall).
2. Cardiology vs nephrology friction: cardiology wants GDMT protection, nephrology wants staged renal-safe restart. Neither is "the winner"; correct answer stages the restart against parameters.
3. Buried functional/cognitive evidence: OT medication-sorting errors, nursing "I think so," Morse 65 fall risk - distributed across files, must be surfaced into a safety plan.
4. Inpatient-only vs outpatient separation: correctional lispro and IV fluids must not carry forward; the empiric antibiotic needs a disposition.
5. The discharge-facing snapshot is reassuring-but-incomplete; must be reconciled against the full chart, not copied.

## Batch v2 results (the evidence)
10 trajectory scores: 78, 72, 92, 95, 93, 92, 92, 92, 90, 94. Mean 89%, range 72-95, ZERO below 70.
Taiga QA: Env Linter clean; one Data Quality false positive (model-access preflight) dismissed as tech issue. Grading infra verified correct (golden absent from rollout container, no reward hacking).
Platform calibration heuristic: <70% = task stumps the model (good); >70% = task may be too easy.

Two trajectories were read in full initially and both looked clinically strong on trap handling: no fabrication, prednisone not fixed to a bogus home dose, full cardiorenal restart reasoning, buried OT/nursing evidence surfaced, lispro excluded, antibiotic disposition addressed.

Important transcript update: grading transcripts were then pulled for the 0.72 run (564d568d) and 0.78 run (aef58074). This reversed the earlier "possible grader underscore" hypothesis. Both lower-scoring runs lost points for a real omission: metformin ER 500 mg BID was omitted from the medication disposition entirely. The 0.78 run also under-dispositioned gabapentin. Metformin was item 8 of the 19-item home list, was held HD1-HD6 in the MAR, was nephrology-held, and was explicit in the golden. The grader independently verified the omission against primary chart sources and did not accept the model's "18 of 19 reconciled" claim.

The same grading transcript also validated the v4 /docs-aware fabrication clause: the grader recognized chart-sourced specifics such as creatinine trend, potassium trend, and 97 kg as supported rather than fabricated.

Additional local-output check: saved trajectory outputs in `task1/trajectories/low-runs/` confirmed the discriminator. Run 564d568d (0.72) contains zero metformin mentions; run 5037a531 from the 90s cluster mentions metformin four times and covers gabapentin four times. So the score separation tracks medication-list completeness, not hidden trap reasoning.

## Working-Claude's draft FA position (critique this)
- The task does not strongly stump claude-opus-4-6 in raw calibration terms (0/10 below 70), so it still leans tractable.
- But the score spread is now meaningful, not vague. The lower runs missed a quiet held oral antidiabetic while correctly handling higher-salience traps like HFrEF GDMT, prednisone ambiguity, lispro exclusion, and antibiotic disposition.
- The residual failure mode is medication-list completeness under load: the model can reason well around the dramatic issues but still drop a clinically important held chronic medication.
- That is a real discharge medication reconciliation safety failure and fits the purpose of Task 1.
- Conclusion: KM01 is well-built and clinically discriminating, though not deeply stumping for this model generation. FA should lead with silent metformin omission / self-audit failure under 19-medication load, not with a generic "too easy" frame.

## Working-Claude's draft GA position (critique this)
- Aggregate grading is sensible: strong answers in the 90s, weaker answers in the 70s, no reward hacking, golden not leaked.
- The 0.78 on aef58074 is no longer best framed as an underscore. The grader caught a true metformin omission and partial gabapentin under-disposition.
- GA likely rating: Good/Great. The grader verified against primary chart sources, penalized a real omission, and did not false-flag accurate chart-sourced specifics as fabrication.
- Physician judgment question: whether a complete omission of a held chronic medication in a discharge reconciliation should be penalized more steeply than 0.78. That is a calibration nuance, not a grader failure. Recommended rating frame: Good/Great, with Great defensible if the grader consistently credits a 90s run for metformin coverage.

## Questions for you, the independent reviewer
1. Is "accept-and-document as well-built, clinically discriminating, but not deeply stumping" the correct disposition for KM01?
2. Should the GA rate the grader as Good or Great given that it caught metformin omission and validated chart-sourced specifics, or should it note that 0.78 may be slightly generous for a full held-med omission?
3. How should the FA phrase the failure mode: model handled high-salience traps but missed a quieter held chronic med under 19-item reconciliation load?
4. Anything in the revised position that is anchored, overstated, or resting on a premise not actually verified from the grading transcripts?

Boundary: propose specific wording as candidates; the physician finalizes. Do not soften clinical content.
